TamoRx is a Biotech company that is focused on research and development of biological mechanism within cells for cancer treatment.
TamoRx has raised $9.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.
TamoRx's investors include Brandon Capital, University of Auckland Inventors Fund.
TamoRx is headquartered in Auckland, New Zealand.
TamoRx is a Biotech company that is focused on research and development of biological mechanism within cells for cancer treatment.
TamoRx is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TamoRx — Funding & Investors." VCBacked, June 6, 2022, https://www.vcbacked.co/company/tamorx. Accessed August 15, 2026.
VCBacked. (2022). TamoRx — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/tamorx
{{cite web |title=TamoRx — Funding & Investors |url=https://www.vcbacked.co/company/tamorx |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated